» Articles » PMID: 20064257

Genetic Copy Number Variants in Sib Pairs Both Affected with Schizophrenia

Overview
Journal J Biomed Sci
Publisher Biomed Central
Specialty Biology
Date 2010 Jan 13
PMID 20064257
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Schizophrenia is a complex disorder with involvement of multiple genes.

Methods: In this study, genome-wide screening for DNA copy-number variations (CNVs) was conducted for ten pairs, a total of 20 cases, of affected siblings using oligonucleotide array-based CGH.

Results: We found negative symptoms were significantly more severe (p < 0.05) in the subgroup that harbored more genetic imbalance (n >== 13, n = number of CNV-disrupted genes) as compared with the subgroup with fewer CNVs (n <== 6), indicating that the degree of genetic imbalance may influence the severity of the negative symptoms of schizophrenia. Four central nervous system (CNS) related genes including CCAAT/enhancer binding protein, delta (CEBPD, 8q11.21), retinoid x receptor, alpha (RXRA, 9q34.2), LIM homeobox protein 5 (LHX5, 12q24.13) and serine/threonine kinase 11 (STK11, 19p13.3) are recurrently (incidence >== 16.7%) disrupted by CNVs. Two genes, PVR (poliovirus receptor) and BU678720, are concordantly deleted in one and two, respectively, pairs of co-affected siblings. However, we did not find a significant association of this BU678720 deletion and schizophrenia in a large case-control sample.

Conclusions: We conclude that the high genetic loading of CNVs may be the underlying cause of negative symptoms of schizophrenia, and the CNS-related genes revealed by this study warrant further investigation.

Citing Articles

The lemur tail kinase family in neuronal function and disfunction in neurodegenerative diseases.

Larose A, Miller C, Morotz G Cell Mol Life Sci. 2024; 81(1):447.

PMID: 39520508 PMC: 11550312. DOI: 10.1007/s00018-024-05480-0.


Transcriptional control of nucleus accumbens neuronal excitability by retinoid X receptor alpha tunes sensitivity to drug rewards.

Godino A, Salery M, Durand-de Cuttoli R, Estill M, Holt L, Futamura R Neuron. 2023; 111(9):1453-1467.e7.

PMID: 36889314 PMC: 10164098. DOI: 10.1016/j.neuron.2023.02.013.


A Potential Autophagy-Related Competing Endogenous RNA Network and Corresponding Diagnostic Efficacy in Schizophrenia.

Li R, Wang Q, Qiu Y, Meng Y, Wei L, Wang H Front Psychiatry. 2021; 12:628361.

PMID: 33708146 PMC: 7940829. DOI: 10.3389/fpsyt.2021.628361.


Regulation of striatal dopamine responsiveness by Notch/RBP-J signaling.

Toritsuka M, Kimoto S, Muraki K, Kitagawa M, Kishimoto T, Sawa A Transl Psychiatry. 2017; 7(3):e1049.

PMID: 28267151 PMC: 5416667. DOI: 10.1038/tp.2017.21.


Gene expression profiling of the dorsolateral and medial orbitofrontal cortex in schizophrenia.

Mladinov M, Sedmak G, Fuller H, Babic Leko M, Mayer D, Kirincich J Transl Neurosci. 2017; 7(1):139-150.

PMID: 28123834 PMC: 5234522. DOI: 10.1515/tnsci-2016-0021.


References
1.
Wang S, SUN C, Walczak C, Ziegle J, Kipps B, Goldin L . Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22. Nat Genet. 1995; 10(1):41-6. DOI: 10.1038/ng0595-41. View

2.
Millar J, Christie S, Anderson S, Lawson D, Devon R, Arveiler B . Genomic structure and localisation within a linkage hotspot of Disrupted In Schizophrenia 1, a gene disrupted by a translocation segregating with schizophrenia. Mol Psychiatry. 2001; 6(2):173-8. DOI: 10.1038/sj.mp.4000784. View

3.
Goodman A . Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci U S A. 1998; 95(13):7240-4. PMC: 33865. DOI: 10.1073/pnas.95.13.7240. View

4.
Goodman A . Congenital anomalies in relatives of schizophrenic probands may indicate a retinoid pathology. Schizophr Res. 1996; 19(2-3):163-70. DOI: 10.1016/0920-9964(96)88523-9. View

5.
KRINGLEN E . Twin studies in schizophrenia with special emphasis on concordance figures. Am J Med Genet. 2000; 97(1):4-11. DOI: 10.1002/(sici)1096-8628(200021)97:1<4::aid-ajmg2>3.0.co;2-j. View